Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Natalie Sacarakis
02.03.25 -- Optimizing Your Trial With The Patient In Mind
Is it time to turn the page on your trial management practices? Join us Feb. 11-13 for Clinical Leader Solutions Expo: Tech Week as experts across EDC, IRT, and eCOA introduce the latest in technologies. We’ll help you discover whether it’s time to write your next chapter and connect you with the partners ready to help you do so – all from the convenience of your computer. Register today and finish your clinical trials story strong. What Is "Patient-Centric" About A Clinical Trial?
10.23.24 -- How One Biotech Is Using FDA 505(b)(2) To Get Drugs To Patients Quicker And Cheaper
Webinar: Unleash the Power of IQVIA Complete Consent The eConsent market is evolving, focusing on improving patient experiences, streamlining clinical trial processes, and global expansion. Staying informed on industry developments is crucial.
04.24.24 -- 4 Takeaways From Building A Differentiated Franchise In Clinical Immunology
A Full-Service Outsourcing Partner With 97% Customer Retention inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor.
08.02.23 -- A DCT Strategy To Improve Patient Experience & Accessibility
You're receiving the Wednesday edition of the Clinical Leader newsletter, focusing on Decentralized Trials and Trial Management. To make changes to your newsletter selections, update your topic preferences. Clinical Sites | Patient Centricity | Patient Recruitment (Monday) Clinical Trial Technology (Tuesday) Decentralized Trials | Trial Management (Wednesday) Outsourcing Models | Regulatory & Compliance (Thursday) (Friday) Learn more about our personalized newsletters here.
Cell And Gene Therapy Logistics Management: A Holistic Approach
By Natalie Sacarakis, Head, Cell and Gene Therapy Logistics, IQVIA CAGT Center of Excellence Cell and gene therapy (CAGT) clinical trial operations exhibit defining characteristics such as intricate protocols, the management of expensive and irreplaceable assets, and accelerated timelines. Furthermore, autologous and allogeneic cell therapies, as well as in vivo and ex vivo gene therapies and gene editing, each have distinct logistics needs.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Natalie
Contact Natalie, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack